Dental Soft Tissue Indications for: Incision, excision, vaporization, ablation and coagulation of oral soft tissues, including marginal and inter-dental gingival and epithelial lining of free gingiva and the following specific indications: - Excisional and incisional biopsies - Exposure of unerupted teeth - A Fibroma removal - A Frenectomy - V Frenotomy - A Gingival troughing for crown impressions - ア Gingivectomy - ア Gingivoplasty - ﺗﯜ Gingival incision and excision - ﺮ Hemostasis and coagulation - ア Implant recovery - ア Incision and drainage of abscess - ア Leukoplakia - ﺮ Operculectomy - ア Oral papillectomies - > Pulpotomy - ア Pulpotomy as an adjunct to root canal therapy - ﻟﻠﺘﺮ Reduction of gingival hypertrophy - Soft tissue crown lengthening A - A Treatment of canker sores, herpetic and aphthous ulcers of the oral mucosa - A Vestibuloplasty Laser Periodontal procedures, including: - A Laser soft tissue curettage - A Laser removal of discased, inflamed and necrosed soft tissue within the periodontal pocket - A Sulcular debridement (removal of diseased, inflamed and necrosed soft tissue in the periodontal pocket to improve clinical indices including gingival index, gingival bleeding index, probe depth, attachment loss and tooth mobility.)

Device Description

The ezlase™ 10W dental diode laser system may be used to perform various dental soft tissue applications. The system uses advanced laser technology to incise, excise, vaporize, coagulate and ablate intraoral soft tissues. An Indium Gallium Arsenide Phosphorus solid-state laser diode emits infrared laser energy to the various oral soft tissues targeted during a procedure. This energy is transmitted via a flexible fiberoptic cable to the handpiece that emits the energy to the targeted tissue site. A visible light is emitted at the same time to visually pinpoint the treatment location. The power output and pulse width may be adjusted to specific user requirements.

AI/ML Overview

This document does not describe an acceptance criteria or a study that proves the device meets specific acceptance criteria.

Instead, this document is a 510(k) summary statement for the Biolase ezlase™ 10W dental diode laser system. It focuses on demonstrating substantial equivalence to previously cleared predicate devices (ezlase™ K061898 and Twilight™ K991994) for its stated indications for use.

Here's why the requested information cannot be extracted from this document:

No Acceptance Criteria or Performance Data: The document lists the device's indications for use and describes its technology but does not provide any quantitative metrics, thresholds, or performance targets that the device must meet (i.e., acceptance criteria). Consequently, there is no "reported device performance" to compare against such criteria.
No Study Described: The document explicitly states, "There are no new indications requested for this device in this Special 510(k). Substantial equivalency for the ezlase™ 10W has been determined through comparison to previously cleared devices." This indicates that no new clinical study was conducted or is being presented as part of this submission to demonstrate the device's efficacy or safety. The approval is based on its similarity to existing, cleared devices.

Therefore, since no study is presented, the subsequent questions about sample size, data provenance, experts, adjudication, MRMC studies, standalone performance, ground truth, and training set information are not applicable to this document.

Summary

{0}------------------------------------------------

NOV 1 3 2008

Biolase Technology, Inc. Special 510(k) Summary Statement ezluse™ 10W CONFIDENTIAL

510(k) SPECIAL Summary (As required by 21CFR807.92, 21CFR807.81(a)(3), FDA Mcmorandum #K97-1)

K083069

Date Prepared:	October 13, 2008
Company:	Biolase Technology, Inc.4 CromwellIrvine, CA 92618Tel: (949) 361-1200Fax: (949) 273-6680
Contact:	Ms. Ioana M. RizoiuVP, Clinical R&DTel: (949) 226-8144email: irizoiu@biolase.com
Trade Name:	ezlase™ 10W
Common Name:	Dental Diode Laser
Classification Name:	Surgical laser instrument
Classification Code:	79 GEX, a Class II device
Predicate Devices:	ezlase™Biolase Technology, IncK061898 (January 26, 2007)Twilight™Biolase Technology, IncK991994 (September 10, 1999)

DEVICE DESCRIPTION:

{1}------------------------------------------------

INDICATIONS FOR USE:

Dental Soft Tissue Indications for:

Incision, excision, vaporization, ablation and coagulation of oral soft tissues, including marginal and inter-dental gingival and epithelial lining of free gingiva and the following specific indications:

Excisional and incisional biopsies
Exposure of unerupted teeth
A Fibroma removal
A Frenectomy
V Frenotomy
A Gingival troughing for crown impressions
ア Gingivectomy
ア Gingivoplasty
ﺗﯜ Gingival incision and excision
ﺮ Hemostasis and coagulation
ア Implant recovery
ア Incision and drainage of abscess
ア Leukoplakia
ﺮ Operculectomy
ア Oral papillectomies
Pulpotomy
ア Pulpotomy as an adjunct to root canal therapy
ﻟﻠﺘﺮ Reduction of gingival hypertrophy
Soft tissue crown lengthening A
A Treatment of canker sores, herpetic and aphthous ulcers of the oral mucosa
A Vestibuloplasty

Laser Periodontal procedures, including:

A Laser soft tissue curettage
A Laser removal of discased, inflamed and necrosed soft tissue within the periodontal pocket
A Sulcular debridement (removal of diseased, inflamed and necrosed soft tissue in the periodontal pocket to improve clinical indices including gingival index, gingival bleeding index, probe depth, attachment loss and tooth mobility.)

CONTRAINDICATIONS:

All clinical procedures performed with the ezlase™ 10W must be subjected to the same clinical judgment and care as with traditional techniques. Patient risk must always be considered and fully understood before clinical treatment. The clinician must completely understand the patient's medical history prior to treatment. Exercise caution for general medical conditions, which might contraindicate a local procedure. Such conditions may include allergy to local or topical anesthetics, heart disease, lung disease, bleeding disorders, sleep apnea, and immune system deficiency, or any medical conditions or medications that may contraindicate use of certain

{2}------------------------------------------------

light/laser type sources associated with this device. Medical clearance from the patient's physician is advisable when doubt exists regarding treatment.

CONCLUSION:

There are no new indications requested for this device in this Special 510(k). Substantial equivalency for the ezlaxe™ 10W has been determined through comparison to previously claared devices.

{3}------------------------------------------------

Image /page/3/Picture/11 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with its wings spread, and the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle. The eagle is black, and the text is also black. The logo is simple and recognizable.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Biolase Technology, Inc. % Ms. Ioana Rizoiu VP, Clinical Research & Development 4 Cromwell Irvine, California 92618

NOV 1 3 2008

Re: K083069 Trade/Device Name: ezlase™ 10W Regulation Number: 21 CFR 878.4810 Regulation Name: Laser surgical instrument for use in general and plastic surgery and in dermatology Regulatory Class: II Product Code: GEX Dated: October 13, 2008 Received: October 15, 2008

Dear Ms. Rizoiu:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the cnactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labcling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{4}------------------------------------------------

Page 2 - Ms. Ioana Rizoiu

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket survcillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Survcillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilitics under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely vours.

Mark N. Wilkerson

Mark N. Melkerson Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Indications for Use Statement

510(k) Number: K 08306

Device (Trade) Name: ezlase™ 10W

Indications for Use:

Dental Soft Tissue Indications for:

Incision, excision, vaporization, ablation and coagulation of oral soft tissues. including marginal and inter-dental gingival and epithelial lining of free gingiva and the following specific indications:

Excisional and incisional biopsies
Exposure of unerupted teeth
Fibroma removal
Frenectomy
Frenotomy
Gingival troughing for crown impressions
Gingivectomy
Gingivoplasty
Gingival incision and excision
Hemostasis and coagulation
Implant recovery
Incision and drainage of abscess
Leukoplakia
Operculectomy
Oral papillectomies
Pulpotomy
Pulpotomy as an adjunct to root canal therapy
Reduction of gingival hypertrophy
Soft tissue crown lengthening
Treatment of canker sores, herpetic and aphthous ulcers of the oral mucosa
▷ Vestibuloplasty

(Division Sign-Off) Division of General, Restorative, and Neurological Devices

510(k) Number K083069

{6}------------------------------------------------

Laser Periodontal procedures, including:

Laser soft tissue curettage
Lascr removal of discased, infected, inflamed and necrosed soft tissue within the periodontal pocket
Sulcular debridement (removal of diseased, inflamed and necrosed soft tissue in the periodontal pocket to improve clinical indices including gingival index, gingival bleeding index, probe depth, attachment loss and tooth mobility.)

Prescription Use X (Part 21 CFR 801 Subpart D)

AND/OR

Over-the-Counter Use_ (21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off) (Division Sign of General, Restorative, Division of Neurological Devices

510(k) Number K083069

Regulation Number and Section

§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.

(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.